Last reviewed 2026-04-20 · How we verify

Tumor samples

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Infections and Infestations, other
• Anal pain
• Anal hemorrhage
• Neoplasms, other
• Diarrhea
• Anal fissure
• Constipation
• Hemorrhoids
• Anorectal infection
• Surgical and Medical procedures, other
• Hypertension
• Cardiac Disorders, Other

Key clinical trials

• Collection of Blood From Patients With Prostate Cancer
• Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm (PHASE2)
• The Effects of 5G Radiation on Skin (NA)
• Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma (PHASE1)
• Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML (PHASE1)
• Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer (PHASE1)
• Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia (PHASE2)
• NCI COVID-19 in Cancer Patients, NCCAPS Study

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Tumor samples CI brief — competitive landscape report
• Tumor samples updates RSS · CI watch RSS
• Assistance Publique - Hôpitaux de Paris portfolio CI